Preeclampsia

Maternal mortality rates in the U.S. have declined since 2021 and 2022, but disparities remain for Black and Indigenous women, who are more than three times more likely to die during pregnancy and postpartum, according to CDC data.

Editor’s Note: This is part three of a three-part Healio Exclusive series on maternal and cardiovascular outcomes among Indigenous women living in the United States. Part one can be seen here. Part two can be seen here.

ChatGPT 3.0 generated satisfactory responses when asked common pregnancy questions, but responses became inconsistent when asked various iterations of the same question, data show.

American Indian and Alaska Native communities are some of the most underserved minoritized groups in the United States, and Indigenous women are most likely to confront the health-related consequences, particularly during pregnancy.

The Preeclampsia Foundation launched a new initiative that aims to close the maternal health equity gap and promote the use of low-dose aspirin to reduce preeclampsia risk in Black women.

Recent research reported that women with endometriosis have an approximately 20% increased risk for stroke and a 35% greater risk for heart attack compared with women without endometriosis.

Women who experience adverse pregnancy outcomes such as preeclampsia or gestational diabetes are at high risk for CVD, yet many of these women are not properly assessed and followed during the critical postpartum period.

CHICAGO — Black and Hispanic women who adhered to components of a Mediterranean-style diet were less likely to experience any adverse pregnancy outcome, regardless of overweight or obesity status, researchers reported.

A blood test to measure fibrinogen-to-albumin ratio predicted preeclampsia and severe preeclampsia risk in laboring women compared with other blood markers, potentially providing a useful tool for anesthesiologists, researchers reported.

Screening pregnancies without traditional risk factors for spontaneous preterm birth risk with a biomarker blood test and targeting preventive treatments for high-risk women reduced neonatal hospitalization, morbidity and mortality.